Search Results - "HANSEN, T. W"

Refine Results
  1. 1
  2. 2

    Reduction of nickel oxide particles by hydrogen studied in an environmental TEM by Jeangros, Q., Hansen, T. W., Wagner, J. B., Damsgaard, C. D., Dunin-Borkowski, R. E., Hébert, C., Van herle, J., Hessler-Wyser, A.

    Published in Journal of materials science (01-04-2013)
    “…In situ reduction of nickel oxide (NiO) particles is performed under 1.3 mbar of hydrogen gas (H 2 ) in an environmental transmission electron microscope…”
    Get full text
    Journal Article
  3. 3

    In situ redox cycle of a nickel–YSZ fuel cell anode in an environmental transmission electron microscope by Jeangros, Q., Faes, A., Wagner, J.B., Hansen, T.W., Aschauer, U., Van herle, J., Hessler-Wyser, A., Dunin-Borkowski, R.E.

    Published in Acta materialia (01-08-2010)
    “…Environmental transmission electron microscopy is used in combination with density functional theory calculations to study the redox stability of a…”
    Get full text
    Journal Article
  4. 4

    Mechanical properties of low-density polyethylene filled by graphite nanoplatelets by Carotenuto, G, De Nicola, S, Palomba, M, Pullini, D, Horsewell, A, Hansen, T W, Nicolais, L

    Published in Nanotechnology (07-12-2012)
    “…The mechanical properties of GNP/LDPE nanocomposites (graphite nanoplatelets/low density polyethylene) have been investigated, in order to establish the effect…”
    Get more information
    Journal Article
  5. 5

    Oxidation mechanism of nickel particles studied in an environmental transmission electron microscope by Jeangros, Q., Hansen, T.W., Wagner, J.B., Dunin-Borkowski, R.E., Hébert, C., Van herle, J., Hessler-Wyser, A.

    Published in Acta materialia (01-04-2014)
    “…The oxidation of nickel particles was studied insitu in an environmental transmission electron microscope in 3.2mbar of O2 between ambient temperature and…”
    Get full text
    Journal Article
  6. 6

    Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events by Sehestedt, T, Lyngbæk, S, Eugen-Olsen, J, Jeppesen, J, Andersen, O, Hansen, T.W, Linneberg, A, Jørgensen, T, Haugaard, S.B, Olsen, M.H

    Published in Atherosclerosis (01-05-2011)
    “…Abstract Objective The soluble urokinase plasminogen activator receptor (suPAR) is a plasma marker of low grade inflammation and has been associated with…”
    Get full text
    Journal Article
  7. 7

    International variations in application of the best-interest standard across the age spectrum by Laventhal, N, Verhagen, A A E, Hansen, T W R, Dempsey, E, Davis, P G, Musante, G A, Wiles, A, Meadow, W, Janvier, A

    Published in Journal of perinatology (01-02-2017)
    “…Objective: Ethically and legally, assertions that resuscitation is in a patient’s best interest should be inversely correlated with willingness to forego…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men by Haugaard, S. B., Andersen, O., Hansen, T. W., Eugen-Olsen, J., Linneberg, A., Madsbad, S., Olsen, M. H., Jørgensen, T., Borch-Johnsen, K., Jeppesen, J.

    Published in Diabetic medicine (01-04-2012)
    “…Diabet. Med. 29, 479–487 (2012) Aim  To explore the putative association of new‐onset diabetes and the soluble urokinase plasminogen activator receptor…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Mechanistic aspects of N2O and N2 formation in NO reduction by NH3 over Ag/Al2O3: The effect of O2 and H2 by Kondratenko, V.A., Bentrup, U., Richter, M., Hansen, T.W., Kondratenko, E.V.

    Published in Applied catalysis. B, Environmental (01-12-2008)
    “…A mechanistic scheme of N2O and N2 formation in the selective catalytic reduction of NO with NH3 over a Ag/Al2O3 catalyst in the presence and absence of H2 and…”
    Get full text
    Journal Article
  12. 12

    Atomic-Resolution in Situ Transmission Electron Microscopy of a Promoter of a Heterogeneous Catalyst by Hansen, Thomas W., Wagner, Jakob B., Hansen, Poul L., Dahl, Søren, Topsøe, Haldor, Claus J. H. Jacobsen

    “…Insight into the location, state, and function of a promoter in heterogeneous catalysis was obtained through atomic-resolution in situ transmission electron…”
    Get full text
    Journal Article
  13. 13

    Selective catalytic reduction of NO by ammonia using mesoporous Fe-containing HZSM-5 and HZSM-12 zeolite catalysts: An option for automotive applications by Kustov, A.L., Hansen, T.W., Kustova, M., Christensen, C.H.

    Published in Applied catalysis. B, Environmental (15-11-2007)
    “…Mesoporous and conventional Fe-containing ZSM-5 and ZSM-12 catalysts (0.5–8wt% Fe) were prepared using a simple impregnation method and tested in the selective…”
    Get full text
    Journal Article
  14. 14

    High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes by Zobel, E.H, von Scholten, B.J, Lajer, M, Jorsal, A, Tarnow, L, Rasmussen, L.M, Holstein, Per, Parving, H.-H, Hansen, T.W, Rossing, P

    Published in Journal of diabetes and its complications (01-11-2016)
    “…Abstract Background and aim The bone-related peptide osteoprotegerin has been linked to vascular calcification and peripheral vascular disease. We investigated…”
    Get full text
    Journal Article
  15. 15

    Relation between insulin and aortic stiffness: a population-based study by HANSEN, T. W, JEPPESEN, J, RASMUSSEN, S, IBSEN, H, TORP-PEDERSEN, C

    Published in Journal of human hypertension (01-01-2004)
    “…Recent studies have suggested that a high pulse wave velocity (PWV), a measure of aortic stiffness, may be a stronger risk factor for cardiovascular disease…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes by Hansen, C. S., Theilade, S., Lajer, M., Hansen, T. W., Rossing, P.

    Published in Diabetic medicine (01-11-2018)
    “…Aim To investigate the association between cardiovascular autonomic neuropathy and bone metabolism in people with Type 1 diabetes. Methods We assessed…”
    Get full text
    Journal Article
  18. 18

    Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes by Theilade, S., Lyngbæk, S., Hansen, T. W., Eugen‐Olsen, J., Fenger, M., Rossing, P., Jeppesen, J. L.

    Published in Journal of internal medicine (01-03-2015)
    “…Objectives Soluble urokinase plasminogen activator receptor (suPAR) is a marker of inflammation and endothelial dysfunction. We investigated the associations…”
    Get full text
    Journal Article
  19. 19

    Risk prediction is improved by adding markers of subclinical organ damage to SCORE by Sehestedt, Thomas, Jeppesen, Jørgen, Hansen, Tine W., Wachtell, Kristian, Ibsen, Hans, Torp-Petersen, Christian, Hildebrandt, Per, Olsen, Michael H.

    Published in European heart journal (01-04-2010)
    “…Aims It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects…”
    Get full text
    Journal Article
  20. 20

    Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study by Rosenlund, S., Hansen, T. W., Andersen, S., Rossing, P.

    Published in Diabetic medicine (01-11-2015)
    “…Aim The effect of insulin pump [continuous subcutaneous insulin infusion (CSII)] treatment on diabetes complications in a modern clinical setting is largely…”
    Get full text
    Journal Article